{
  "id": 109,
  "text": "GynecolOncol,2014,132（1）:7680.[]EVIEAVILUalyndsisislgsmgrmdin vical cancerrecurrencerisk:AnNRG/GOG ancillaryanalysis.GynecolOncol2021,162(3）:532-538.[6]HUNGENGWNtlfftivnsfquelhmradtnornmradat radiationaloneinaduvanteamentafterhysterectomyforcervicalcancerTheTARSphase3randomizedclinical trial.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: GynecolOncol,2014,132（1）:7680.[]EVIEAVILUalyndsisislgsmgrmdin vical cancerrecurrencerisk:AnNRG/GOG ancillaryanalysis.GynecolOncol2021,162(3）:532-538.[6]HUNGENGWNtlfftivnsfquelhmradtnornmradat radiationaloneinaduvanteamentafterhysterectomyforcervicalcancerTheTARSphase3randomizedclinical trial.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌接受子宫切除术后的辅助治疗中，单纯放疗与联合化疗放疗的疗效区别主要体现在治疗效果以及副作用上。研究表明，单纯放疗可以有效降低宫颈癌的复发风险，对于特定风险较低的患者可能是合适的选择。然而，联合化疗放疗则通常被认为能够进一步降低癌症的复发可能，特别是在治疗高风险患者时更为优效。联合化疗放疗尽管增加了治疗的复杂性，但可以通过综合作用提高疗效。然而，联合治疗可能会带来更多的副作用，包括但不限于骨髓抑制、消化道反应和其他化疗相关的不良反应。因此，在选择治疗方案时，需要综合考虑患者的具体情况和相应风险，以便权衡利弊。",
  "query": "问题：在宫颈癌接受子宫切除术后的辅助治疗中，单纯放疗与联合化疗放疗的疗效区别是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 问题：在宫颈癌接受子宫切除术后的辅助治疗中，单纯放疗与联合化疗放疗的疗效区别是什么？\n\n<reference text>: GynecolOncol,2014,132（1）:7680.[]EVIEAVILUalyndsisislgsmgrmdin vical cancerrecurrencerisk:AnNRG/GOG ancillaryanalysis.GynecolOncol2021,162(3）:532-538.[6]HUNGENGWNtlfftivnsfquelhmradtnornmradat radiationaloneinaduvanteamentafterhysterectomyforcervicalcancerTheTARSphase3randomizedclinical trial.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌接受子宫切除术后的辅助治疗中，单纯放疗与联合化疗放疗的疗效区别主要体现在治疗效果以及副作用上。研究表明，单纯放疗可以有效降低宫颈癌的复发风险，对于特定风险较低的患者可能是合适的选择。然而，联合化疗放疗则通常被认为能够进一步降低癌症的复发可能，特别是在治疗高风险患者时更为优效。联合化疗放疗尽管增加了治疗的复杂性，但可以通过综合作用提高疗效。然而，联合治疗可能会带来更多的副作用，包括但不限于骨髓抑制、消化道反应和其他化疗相关的不良反应。因此，在选择治疗方案时，需要综合考虑患者的具体情况和相应风险，以便权衡利弊。"
}